News and Trends 14 Jul 2022 GenScript ProBio enters strategic partnerships with two South Korean biotechs GenScript ProBio, the CDMO segment of the leading biotech GenScript, has entered into a strategic partnership memorandum of understanding (MOU) with DAAN Bio Therapeutics for the discovery and development of novel drugs and with ACT Therapeutics to develop new CAR-T cell therapies. With offices located in the U.S., the Netherlands, China, Singapore and Japan, GenScript […] July 14, 2022 - 3 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
News and Trends 13 Jul 2022 First aseptic filling line and facilities completed in Taiwan The construction of a fully-automated aseptic filling line and facilities has been finished in Taiwan. Amaran Biotechnology Inc., a subsidiary of Taiwan’s OBI Pharma Inc., made the announcement that the new facility, a first for the country, minimizes the risks of human factors affecting the quality of pharmaceutical products, and enhances their safety. The project […] July 13, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 1 Jul 2022 Continuous cell culture paves the way for better biomanufacturing The development of continuous cell culture technologies is cutting the costs and resources required for biomanufacturing, benefiting biotech processes ranging from growing cultured meat to manufacturing drugs. The idea of replacing livestock with cell culture to produce meat could reduce animal cruelty, lower greenhouse gas emissions and would require far less land to produce equivalent […] July 1, 2022 - 6 minutesmins - By Sachin Rawat Share WhatsApp Twitter Linkedin Email
News and Trends 23 Jun 2022 Antheia gets funding to build biomanufacturing plant Antheia, a U.S. synthetic biology company enabling next-generation plant-inspired medicines, has announced $40 million in venture debt financing from Oxford Finance LLC and Silicon Valley Bank. The company also unveiled plans to construct a new pilot scale biomanufacturing facility. The financing will support Antheia’s expansion with a 14,700 square-foot pilot plant located next to Antheia’s […] June 23, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jun 2022 Aussie uni develops new 3D printing solution for stem cell manufacturing Researchers at the University of Technology Sydney (UTS), Australia, have developed a 3D printed system for harvesting stem cells from bioreactors. The scientists said this could lead to high quality, wide-scale production of stem cells in Australia at a lower cost. Stem cells offer great promise in the treatment of many diseases and injuries, from […] June 21, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 16 Jun 2022 Clean and green: Unilever and Geno launch $120m palm oil alternatives venture Unilever and U.S. biotech company Genomatica (Geno) are working on a plan to scale and commercialize alternatives to palm oil and fossil fuel-derived cleansing ingredients. The companies said due to growing demand for sustainably-sourced palm oil, they aim to deliver new responsibly-sourced palm oil alternatives to the market. With $120m jointly invested in the newly-formed […] June 16, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 10 May 2022 eureKARE Launches €150M Merger to Form Cell and Gene Therapy CDMO The French startup creator eureKARE has set up a special purposes acquisition company (SPAC) with the ambition to merge multiple European contract development and manufacturing organizations into a heavyweight serving developers of gene therapies, protein drugs, and microbiome therapeutics. Over the last few years, record levels of funding have flowed into the biotech industry, particularly […] May 10, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 19 Apr 2022 How Augmented Reality Strengthens Biotech Manufacturing Biotech and pharma companies are starting to implement augmented reality technologies at their manufacturing facilities, bringing forth a whole new world of possibilities. The Covid-19 pandemic has been a catalyst for embracing new ways of working. Travel restrictions and limited access to facilities have pushed the adoption of technologies that enhance remote work. This is […] April 19, 2022 - 8 minutesmins - By Carlos de Rojas Share WhatsApp Twitter Linkedin Email
Expert Advice 21 Mar 2022 How to Set up Manufacturing for Biotech Startups Deciding when and how to set up manufacturing can be essential to the success of any biotech startup. Experts share their advice on how to approach manufacturing decisions. Great ideas for potential biotech products, often hatched in small startup settings, seem far removed from the complexities of manufactcduring later down the line. Researchers and innovators […] March 21, 2022 - 8 minutesmins - By Matthew Williams Share WhatsApp Twitter Linkedin Email
News and Trends 18 Jan 2022 Ori Biotech Bags €88M Investment to Automate Cell Therapy Manufacture The UK company Ori Biotech has raised €88M ($100M) in Series B cash to ease the cell therapy manufacturing bottleneck using automation and standardized data collection. The round was 40% oversubscribed and led by the US investment firm Novalis LifeSciences. The Chinese investor Puhua Capital and Chimera Abu Dhabi joined the existing syndicate, which includes […] January 18, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Sponsored by Cytiva 18 Jan 2022 How to Make Cell Culture Expansion Easy Cell culture expansion for biotherapeutic development has traditionally involved a series of time-consuming, labor-intensive batch cultures that are susceptible to contamination. Cell culture expansion using a perfusion process promises easy scalability, ensures high productivity gains, and saves time and costs during large-scale biomanufacturing. Cell culture is a crucial tool in the biotech sector. Applications range […] January 18, 2022 - 7 minutesmins - By Sudha Sundaram Share WhatsApp Twitter Linkedin Email
Opinion 3 Jan 2022 Distributed Manufacturing of Cell Therapies Poses a Threat to Big Pharma As medical institutions develop the infrastructure for decentralized manufacturing of cell therapies, they are positioned to outperform big pharma’s limited success with a centralized approach to manufacturing. A revolution is coming in the discovery, development and delivery of living medicines. This revolution is being led by well-funded, elite academic medical centers, such as the University […] January 3, 2022 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email